Optimising both disease control and glucocorticoid dosing is essential for bone protection in patients with rheumatic disease.
Edgar WiebeDörte HuscherDésireé SchaumburgAndriko PalmowskiSandra HermannThomas ButtgereitRobert BiesenGerd-Rüdiger R BurmesterYannick PalmowskiMaarten BoersJohn H StoneChristian DejacoFrank ButtgereitPublished in: Annals of the rheumatic diseases (2022)
NCT02719314.
Keyphrases